App Diagnoses Respiratory Diseases Through a Cough Into a Smartphone

The app ResApp can diagnose respiratory disease conditions including pneumonia, asthma, bronchiolitis and chronic obstructive pulmonary disease.

An app that can diagnose respiratory diseases has been developed by an Australia-based digital health solution provider. The app diagnoses diseases like pneumonia, croup, and asthma with high accuracy through a cough into a smartphone.

The app ResApp has been developed by Perth-based ResApp Health. A recent clinical study of 524 pediatric patients at the West Australian city's Joondalup Health Campus and Princess Margaret Hospital found that the smartphone-based system can achieve an overall accuracy of 89 percent, the West Australian reported.

Acute Respiratory Disease Cases On Rise In India Due To Air Pollution: Health Ministry Report
Air pollution leads to a wide array of health effects, of which ARI has accounted for the maximum number of cases. Around 3.5 crore ARI cases were reported in 2014.

‘The smartphone-based app ‘ResApp’ can detect respiratory illnesses with an overall accuracy of 89 percent. ’

ResApp has been developing machine-learning algorithms that will automatically determine which respiratory condition a patient might have, including pneumonia, asthma, bronchiolitis, and COPD -- an umbrella term used to describe progressive lung diseases.

The company released data from this trial previously in November, but that data set included fewer patients.

The larger group is now starting to show ResApp's effectiveness in diagnosing less common conditions.

Drug by GlaxoSmithKline Fails To Prolong Life In Patients With Chronic Respiratory Disease
While Breo did lower the risk of dying by 12.2 percent compared to placebo, the difference was not big enough to be deemed statistically significant.

"We are pleased to report again high levels of accuracy on a dataset that is more than 50 percent larger than the previously used dataset," Tony Keating, CEO and managing director of ResApp, said in a statement.

"These updated results reaffirm the algorithm's clinical accuracy right before we enter the pivotal studies needed for our upcoming premarket submission to the US Food and Drug Administration," he added.

Management of Respiratory Diseases Beyond Drugs
A panel discussion on Pulmonary Rehabilitation (PR) of patients of respiratory diseases was held as part of the 20th National Conference on Environmental Sciences and Pulmonary Diseases.

Also, these preliminary results for the separation of bacterial and atypical pneumonia from viral pneumonia are very exciting as they demonstrate the power of ResApp's algorithm in supporting clinicians in making critical decisions for patient treatment," Keating noted.

Source-IANS

Novel Virus That Could Cause Respiratory Disease in Ball Pythons Identified
A novel virus that could be the source of a severe, sometimes fatal respiratory disease that has been observed in captive ball pythons since the 1990s has been discovered by scientists.